RTW Biotech Opportunities Ltd
RTWFF
$1.64
$0.2820.59%
OTC PK
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | -- |
Total Other Revenue | 936.90% | 936.90% | 132.83% | 132.83% | 52.24% |
Total Revenue | 936.90% | 936.90% | 132.83% | 132.83% | 52.24% |
Cost of Revenue | -- | -- | -- | -- | -- |
Gross Profit | 936.90% | 936.90% | 132.83% | 132.83% | 52.24% |
SG&A Expenses | 19.12% | 19.12% | 79.48% | 79.48% | 58.32% |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | 23.88% | 23.88% | 82.26% | 82.26% | 56.87% |
Operating Income | 972.22% | 972.22% | 2.19% | 2.19% | -62.22% |
Income Before Tax | -147.46% | -147.46% | -201.86% | -201.86% | 164.15% |
Income Tax Expenses | -- | -- | -- | -- | -- |
Earnings from Continuing Operations | -147.46% | -147.46% | -201.86% | -201.86% | 164.15% |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | -147.46% | -147.46% | -201.86% | -201.86% | 164.15% |
EBIT | 972.22% | 972.22% | 2.19% | 2.19% | -62.22% |
EBITDA | -- | -- | -- | -- | -- |
EPS Basic | -148.28% | -148.28% | -163.87% | -163.87% | 67.06% |
Normalized Basic EPS | -77.59% | -77.59% | -30.18% | -30.18% | 966.67% |
EPS Diluted | -148.28% | -148.28% | -163.87% | -163.87% | 67.06% |
Normalized Diluted EPS | -77.59% | -77.59% | -30.18% | -30.18% | 966.67% |
Average Basic Shares Outstanding | -1.68% | -1.68% | 59.38% | 59.38% | 58.07% |
Average Diluted Shares Outstanding | -1.68% | -1.68% | 59.38% | 59.38% | 58.07% |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |